The CBD industry’s rapid growth has outpaced its regulation, leaving consumers and businesses navigating a confusing and inconsistent landscape. H.R.1629, a bill in Congress, aims to classify CBD as a dietary supplement, introducing much-needed federal standards for safety, labeling, and quality. This legislation is a win for consumers, offering greater transparency and trust, and a boon for businesses, unlocking innovation and economic opportunities. By regulating CBD, H.R.1629 has the potential to safeguard public health, empower industry growth, and solidify the U.S. as a leader in this thriving market. Now is the time for Congress to act.
We use cookies and similar technologies to provide the best experience on our website.
Choosing a selection results in a full page refresh.